Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
J
007370
vs
K
KOSPI 200
Over the past 12 months, Jin Yang Pharmaceutical Co Ltd has underperformed KOSPI 200, delivering a return of -34% compared to KOSPI 200's +53% growth.
Stocks Performance
007370 vs KOSPI 200
Performance Gap
007370 vs KOSPI 200
Performance By Year
007370 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jin Yang Pharmaceutical Co Ltd
Glance View
Jin Yang Pharmaceutical Co Ltd is a South Korean drug maker that develops, manufactures, and sells pharmaceutical products. Its business is centered on finished medicines and related health products used to treat common medical conditions. In plain terms, it turns active ingredients into packaged drugs that can be prescribed, dispensed, and sold through the healthcare supply chain. Its customers are mainly pharmacies, hospitals, clinics, wholesalers, and other healthcare distributors that buy medicines for patient use. The company makes money by selling these products under its own brands and, where applicable, by supplying medicines to other companies or healthcare channels. That means its revenue depends on repeat demand for prescription and over-the-counter treatments rather than on one-time projects. What makes this kind of business different is the heavy regulation and manufacturing discipline required to make drugs safely and consistently. Jin Yang Pharmaceutical sits in the part of the industry that converts chemical and medical know-how into standardized products that can be distributed at scale. For investors, that makes it a traditional pharmaceutical manufacturer with a role anchored in production, quality control, and regulated sales channels.